24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs

Clinical trial NCT07543822 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07543822
Sponsor: Children's Hospital of Philadelphia
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Vascular Anomalies Vascular Anomaly TIE2/PIK3CA Pathway Driven Vascular Anomalies

Start date: 2025-08-27
Primary completion: 2029-08-27
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.